For informational purposes only — not investment advice

← Back to signals

LLYVA

Liberty Live Holdings, Inc.

Research: Finviz ↗·Perplexity ↗

No convergence signal this quarter — shown because tracked funds have filed 13D/G on this stock.

Days to cover (short int.)
12.1d-2.6%
as of 2026-07-31

News Summary

Negative

Live Nation (LLYVA's principal asset) delivered strong Q2 2026 results with 9% revenue growth, 10% fan attendance growth, and raised full-year guidance, driving LLYVA stock up 36% from 52-week lows to $101.36. However, a federal jury verdict found Live Nation/Ticketmaster unlawfully monopolized ticketing and amphitheaters, with states formally demanding breakup and unresolved damages/remedy phase presenting material downside risk to LLYVA's core asset value.

Red flags

  • Federal jury verdict against Live Nation on all antitrust counts (unlawful monopolization and tying); states formally demanded Ticketmaster breakup
  • Unresolved damages phase and remedies determination could require forced divestiture of Ticketmaster, core profit driver
  • $450M in legal accruals recognized; final penalties and breakup liability not yet determined
  • Antitrust remedy risk remains material overhang despite near-term operating momentum and stock rally

Fund 13D/13G Filings (3)

Tracked funds' beneficial-ownership filings on this stock — disclosed within days of a position change, fresher than the quarterly 13F. Since Filing compares the stock to SPY from the filing date (shown for filings within the last 90 days).

FundForm∆ Shares% of ClassSince FilingFiledSrc
ValueAct HoldingsSC 13D/A4.9%
+3.9% vs SPY
+5.2% abs
2026-06-15
Berkshire HathawaySC 13GNEW19.5%2026-02-17
ValueAct HoldingsSC 13DNEW7.0%2025-12-19

Tracked Funds Holding (4)

FundManagerShares HeldPosition Value
Berkshire HathawayWarren Buffett10.6M$1.1B
Berkshire HathawayWarren Buffett5.0M$505M
ValueAct HoldingsMason Morfit2.2M$229M
ValueAct HoldingsMason Morfit785K$80M

Quarter-end 13F positions for the tracked funds holding this stock.